Artemisinin CAS#63968-64-9

  • Exceptional Antimalarial Potency: Recognized as a premier therapeutic agent against malaria with over 90% global efficacy, serving as a critical cornerstone in artemisinin-based combination therapies (ACTs).

  • Rapid Parasitic Clearance: Acts with high velocity to eradicate the erythrocytic-stage Plasmodium parasites, delivering prompt clinical relief from acute malarial symptoms.

  • Favorable Low-Toxicity Profile: Characterized by a minimal toxicity index, offering a safe and well-tolerated treatment alternative for malaria and related parasitic infestations.

  • Broad Therapeutic Spectrum: Demonstrates efficacy extending beyond malaria to encompass other parasitic conditions, including avian coccidiosis, toxoplasmosis, and drug-resistant malarial strains.

WhatsApp
Product Details

Recognized as an exceptionally potent therapeutic agent for the treatment of malaria, artemisinin is classified as a sesquiterpene lactone containing a characteristic endoperoxide bridge, extracted from the traditional medicinal plant Artemisia annua. This active compound is distinguished by high clinical efficacy, rapid parasitic clearance, traditional heat-clearing and antipyretic properties, potent antiprotozoal activity, and a remarkably favorable low-toxicity profile.

Artemisinin CAS#63968-64-9

Currently, artemisinin-based combination therapy (ACT) achieves a global malaria treatment efficacy exceeding 90%, leading to its widespread worldwide adoption. The compound delivers a potent and rapid parasitic clearance effect targeting the erythrocytic phase of Plasmodium, enabling swift clinical control of acute malarial episodes and symptoms. Furthermore, it exhibits notable therapeutic efficacy across a diverse array of conditions, including avian coccidiosis, porcine eperythrozoonosis, toxoplasmosis, traditional yin deficiency fever, damp-heat jaundice,Plasmodium vivax malaria, severe malaria, cerebral malaria, and chloroquine-resistant malarial strains.

Artemisinin CAS#63968-64-9

Parameters

Melting point 156-157 °C (lit.)
alpha 76 º (c=0.5,MeOH)
Boiling point 344.94°C (rough estimate)
density 1.0984 (rough estimate)
refractive index 75 ° (C=0.5, MeOH)
storage temp. -20°C
solubility Soluble to 100mM in DMSO and to 75mM in ethanol
form White to off-white crystalline solid.
color Needles
optical activity[α]20/D +76°, c = 0.5 in methanol
Merck 14817
Stability:Stable. Combustible. Incompatible with strong oxidizing agents, acids, acid chlorides, acid anhydrides. May absorb, and react with, carbon dioxide from the air.
InChIInChI=1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1
InChIKeyBLUAFEHZUWYNDE-NNWCWBAJSA-N
SMILESO1[C@]23[C@@]4([H])O[C@@](C)(CC[C@@]2([H])[C@H](C)CC[C@@]3([H])[C@@H](C)C(=O)O4)O1
LogP2.9

Safety Information

Safety Statements 22-24/25
WGK Germany 2
RTECS KD4170000
HS Code 29322985
ToxicityLD50 in mice (mg/kg): 5105 orally; 2800 i.m.; 1558 i.p. (Koch); LD50 in mice, rats (mg/kg): 4228, 5576 orally; 3840, 2571 i.m. (China Cooperative Research Group on Qinghaosu)

Artemisinin CAS#63968-64-9

WhatsApp